⚠️ FOR RESEARCH PURPOSES ONLY — This compound is not FDA approved. All data presented is from clinical trials for educational reference.

Growth Factor Analog Peptide
IGF-1 LR3
An 83-amino acid synthetic analog of human insulin-like growth factor 1 with reduced binding protein affinity and extended half-life, studied for anabolic and tissue growth effects in preclinical research. Premium Research Peptide.
Compound Information
Technical specifications
How It Differs from Native IGF-1
Sources & References
Peer-reviewed research
Insulin-like growth factor-I (IGF-I) and especially IGF-I variants are anabolic in dexamethasone-treated rats
Tomas FM, Knowles SE, Owens PC et al.
Superior potency of infused IGF-I analogues which bind poorly to IGF-binding proteins is maintained when administered by injection
Tomas FM, Lemmey AB, Read LC, Ballard FJ
IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms
Mohan S, Baylink DJ
IGF-1 has plaque-stabilizing effects in atherosclerosis by altering vascular smooth muscle cell phenotype
von der Thüsen JH, Borensztajn KS, Moimas S et al.
Long R3 insulin-like growth factor-I (IGF-I) infusion stimulates organ growth but reduces plasma IGF-I, IGF-II and IGF binding protein concentrations in the guinea pig
Conlon MA, Tomas FM, Owens PC et al.
⚠️Important Research Notice
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.



